Paxlovid Becomes Household Name for Covid-19 Patients
Pfizer’s antiviral drug, called Paxlovid, totaled more than 412,000 prescriptions through May 6, compared with about 110,000 prescriptions of molnupiravir, an antiviral from Merck & Co. and Ridgeback Biotherapeutics LP, according to drug-data firm Iqvia Holdings Inc. Both pills were cleared for use in high-risk individuals early in the course of their disease in December by the U.S. Food and Drug Administration, to keep people from becoming hospitalized.
The Wall Street Journal - May 30, 2022View the full story here: https://www.wsj.com/articles/paxlovid-becomes-household-name-for-covid-19-patients-11653908400?mod=hp_lead_pos8